https://doi.org/10.4081/btvb.2024.147
From rare to aware: confronting Lemierre syndrome
Submitted: 9 July 2024
Accepted: 1 October 2024
Published: 21 October 2024
Accepted: 1 October 2024
Abstract Views: 1648
PDF: 330
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Lemierre syndrome is a life-threatening condition characterized by an acute head/neck bacterial infection due to anaerobes (namely Fusobacterium necrophorum), local septic vein thrombosis and distance septic embolism...
1. Valerio L, Zane F, Sacco C, et al. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases. J Intern Med 2021;289:325-39.
DOI: https://doi.org/10.1111/joim.13114
2. Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936;227:701-703.
DOI: https://doi.org/10.1016/S0140-6736(00)57035-4
3. Hagelskjaer LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995. Eur J Clin Microbiol Infect Dis 1998;17:561-5.
DOI: https://doi.org/10.1007/BF01708619
4. Jones JW, Riordan T, Morgan MS. Investigation of postanginal sepsis and Lemierre's syndrome in the South West Peninsula. Commun Dis Public Health 2001;4:278-81.
5. Hagelskjaer Kristensen L, Prag J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis 2008;27:779-89.
DOI: https://doi.org/10.1007/s10096-008-0496-4
6. Nygren D, Holm K. Invasive infections with Fusobacterium necrophorum including Lemierre’s syndrome: an 8-year Swedish nationwide retrospective study. Clin Microbiol Infect 2020;26:1089.e7-1089.e12.
DOI: https://doi.org/10.1016/j.cmi.2019.12.002
7. Fumagalli RM, Gloor E, Kaufmann PA, et al. Common laboratory tests and their correlation with the clinical presentation and prognosis of Lemierre syndrome. Anaerobe 2023;83:102773.
DOI: https://doi.org/10.1016/j.anaerobe.2023.102773
8. Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 2007;20:622-59.
DOI: https://doi.org/10.1128/CMR.00011-07
9. Sacco C, Zane F, Granziera S, et al. Lemierre Syndrome: clinical update and protocol for a systematic review and individual patient data meta-analysis. Hamostaseologie 2019;39:76-86.
DOI: https://doi.org/10.1055/s-0038-1654720
10. Liesenborghs L, Verhamme P, Vanassche T. Staphylococcus aureus, master manipulator of the human hemostatic system. J Thromb Haemost 2018;16:441-54.
DOI: https://doi.org/10.1111/jth.13928
11. Wani P, Antony N, Wardi M, et al. The forgotten one: Lemierre’s syndrome due to gram-negative rods Prevotella bacteremia. Am J Case Rep 2016;17:18-22.
DOI: https://doi.org/10.12659/AJCR.895560
12. Garbati MA, Ahsan AM, Hakawi AM. Lemierre's syndrome due to Klebsiella pneumoniae in a 63-year-old man with diabetes: a case report. J Med Case Rep 2012;6:97.
DOI: https://doi.org/10.1186/1752-1947-6-97
13. Loof TG, Deicke C, Medina E. The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cell Infect Microbiol 2014;4:128.
DOI: https://doi.org/10.3389/fcimb.2014.00128
14. Valerio L, Corsi G, Sebastian T, Barco S. Lemierre syndrome: current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and Lemierre syndrome (BATTLE) registry. Thromb Res 2020;196:494-9.
DOI: https://doi.org/10.1016/j.thromres.2020.10.002
15. Cupit-Link MC, Nageswara Rao A, Warad DM, Rodriguez V. Lemierre syndrome: a retrospective study of the role of anticoagulation and thrombosis outcomes. Acta Haematol 2017;137:59-65.
DOI: https://doi.org/10.1159/000452855
How to Cite
Cardi, S., Catalani, F., Valerio, L., & Barco, S. (2024). From rare to aware: confronting Lemierre syndrome. Bleeding, Thrombosis and Vascular Biology, 3(3). https://doi.org/10.4081/btvb.2024.147
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso, Antithrombotic therapy in idiopathic infertility , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 3 (2024)
Similar Articles
- Giovanni de Gaetano, Artificial intelligence, platelets and aspirin , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- Simon Noble, Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism? , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024): 12th ICTHIC
- Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia, Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo, Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition? , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Pier Mannuccio Mannucci, Growing weapons to fight hemophilia , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 1 (2023)
- Paola Binetti, Thrombotic thrombocytopenic purpura: much done, but still a lot to do , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol, The new era of anticoagulation: factor XI and XII inhibitors , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Giuseppe Camporese, Paolo Prandoni, Walter Ageno, Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati, It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Ottavia Borghese, Claudio Vincenzoni, Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial” , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
You may also start an advanced similarity search for this article.
